Five Prime Therapeutics, Inc. Restructuring and Related Cost, Expected Cost
Five Prime Therapeutics, Inc. had Restructuring and Related Cost, Expected Cost of $9.38 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Notes › Restructuring and Related Cost, Expected Cost
us-gaap:RestructuringAndRelatedCostExpectedCost1 · last filed 2020-05-07
- 2020-03-31: Restructuring and Related Cost, Expected Cost $9.38M.
| Period end | Restructuring and Related Cost, Expected Cost |
|---|---|
| 2020-03-31 | $9.38M 10-Q · filed 2020-05-07 |